Univariate analysis | Multivariate analysis (model 1 with atrial fibrillation) | Multivariate analysis (model 2 with anticoagulation) | ||||
---|---|---|---|---|---|---|
OR (95% CI) | p value | OR (95% CI) | p value | OR (95% CI) | p value | |
Primary endpoint | ||||||
NYHA ≥III | 5.91 (2.02–17.30) | 0.001 | 6.02 (1.33–18.77) | 0.002 | 6.30 (2.04–19.67) | 0.001 |
Rescue CRT | 0.49 (0.40–0.60) | 0.01 | ||||
CKD | 0.41 (0.16–1.03) | 0.06 | ||||
Loop diuretics | 0.32 (0.09–1.11) | 0.06 | ||||
Anticoagulation | 0.51 (0.23–1.15) | 0.10 | ||||
Atrial fibrillation | 0.51 (0.23–1.15) | 0.10 | ||||
ACEI-ARB | 2.07 (0.84–5.11) | 0.11 | 2.55 (0.91–7.11)) | 0.07 | 2.38 (0.87–6.49) | 0.09 |
Surgery duration | 1.87 (0.85–4.11) | 0.12 | ||||
QRS = 130–150 ms | 0.50 (0.20–1.27) | 0.14 | ||||
One-year mortality | ||||||
Rescue CRT | 58.8 (6.55–528-28) | < 0.001 | 44.67 (2.91–686) | 0.01 | 63.28 (4.47–896) | 0.002 |
CRT-D | 0.23 (0.07–0.75) | 0.01 | ||||
Atrial fibrillation | 4.03 (1.07–15.20) | 0.03 | 6.72 (0.99–45.61) | 0.04 | ||
QRS > 150 ms | 2.64 (0.86–8.15) | 0.08 | 3.79 (0.79–18.21) | 0.10 | ||
Surgery duration | 0.39 (0.13–1.2) | 0.09 | 0.11 (0.02–0.63) | 0.01 | 0.14 (0.03–0.76) | 0.02 |
CKD | 3.54 (0.75–16.67) | 0.09 | ||||
Upgrade | 0.36 (0.08–1.69) | 0.10 | ||||
Anticoagulation | 2.43 (0.72–8.13) | 0.14 | ||||
Beta-blockers | 0.42 (0.12–1.42) | 0.15 | ||||
Ivabradine | 2.63 (0.60–11.41) | 0.18 | 9.99 (1.17–85.42) | 0.04 | 6.36 (1.10–36.90) | 0.04 |
ACEI-ARB | 0.47 (0.15–1.49) | 0.19 |